Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;86(6):860-864.
doi: 10.1053/j.ajkd.2025.06.018. Epub 2025 Sep 4.

A Drug-wide Association Study on Medications Associated With Cystatin C-Estimated GFR

Lesley A Inker  1 , Sneha S Mehta  2 , Alexander R Chang  3 , Saul Blecker  4 , Matthew Blum  5 , Anne-Laure Faucon  6 , Carina Flaherty  2 , Leora I Horwitz  4 , Aditya Surapaneni  2 , Jung-Im Shin  7 , Yunwen Xu  7 , Morgan E Grams  2 , Juan Jesus Carrero  8
Affiliations

A Drug-wide Association Study on Medications Associated With Cystatin C-Estimated GFR

Lesley A Inker et al. Am J Kidney Dis. 2025 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure: MG reports financial support from R01DK115534; R01DK100446; K24HL155861; National Kidney Foundation. LAI reports financial support paid to Tufts Medical Center from the National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (grant 1R01DK116790), National Kidney Foundation, Chinnocks, Alexion and Astra Zeneca; and participation on the medical advisory council for Alport Foundation and the scientific advisory board for National Kidney Foundation. AC reports financial support from R01 DK100446; National Kidney Foundation; financial support paid to Geisinger from Novartis, Boehringer-Ingelheim, and Bayer; and participation on an advisory board for Amgen. JJC has received financial support paid to Karolinska Institutet from AstraZeneca, ViforPharma, Novonordisk, Astellas, MSD and Boehringer Ingelheim; he has also received lecture fees from Fresenius Kabi; and has participated in advisory board for AstraZeneca. JS reports financial support paid to Johns Hopkins University from National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK139324) and Bayer. The remaining authors declare that they have no relevant financial interests.

References

    1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international. April 4 2024;105(4):S117–S314. doi: 10.1016/j.kint.2023.10.018 - DOI - PubMed
    1. Adingwupu OM, Barbosa ER, Palevsky PM, Vassalotti JA, Levey AS, Inker LA. Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review. Kidney Med. Dec 2023;5(12):100727. doi: 10.1016/j.xkme.2023.100727 - DOI - PMC - PubMed
    1. Carrero JJ, Elinder CG. The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care. J Intern Med. Mar 2022;291(3):254–268. doi: 10.1111/joim.13418 - DOI - PubMed
    1. Abbink FC, Laarman CA, Braam KI, et al. Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids. Clinical biochemistry Mar 2008;41(4–5):299–305. doi: 10.1016/j.clinbiochem.2007.11.012 - DOI - PubMed
    1. White CA, Akbari A, Doucette S, et al. Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients. Am J Kidney Dis. Nov 2009;54(5):922–30. doi: 10.1053/j.ajkd.2009.06.003 - DOI - PubMed

LinkOut - more resources